Aldeyra Therapeutics (ALDX) Times Interest Earned (2013 - 2026)
Aldeyra Therapeutics (ALDX) posted Times Interest Earned of -$7.57 for Q1 2026, up 27.58% on a QoQ basis from -$10.45 in Q4 2025, and down 491.83% year-over-year from $1.93 in Q1 2025.
Aldeyra Therapeutics (ALDX) Times Interest Earned (2013 - 2026) Analysis & Trends
Aldeyra Therapeutics' Times Interest Earned history runs 14 years deep, the most recent figure standing at -$7.57 for Q1 2026.
- Quarterly Times Interest Earned fell 491.83% year-over-year to -$7.57 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.13 (down 88.41% YoY) and the FY2025 annual result came in at -$5.34, up 56.62% from the prior year.
- Times Interest Earned was -$7.57 for Q1 2026 at Aldeyra Therapeutics, up from -$10.45 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.59 in Q2 2023 and bottomed at -$39.04 in Q4 2024.
- A 5-year average of -$10.45 and a median of -$7.54 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned soared 94.66% — and 2024, when it sank 6279.56%.
- Aldeyra Therapeutics' Times Interest Earned stood at -$19.23 in 2022, then jumped by 60.81% to -$7.54 in 2023, then sank by 418.01% to -$39.04 in 2024, then surged by 73.23% to -$10.45 in 2025, then advanced by 27.58% to -$7.57 in 2026.
- Business Quant data shows ALDX's Times Interest Earned at -$7.57 in Q1 2026, -$10.45 in Q4 2025, and -$1.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Aldeyra Therapeutics | 95.00 Mn | 95.00 Mn | - | -7.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.57 |
| Dec 31, 2025 | -10.45 |
| Sep 30, 2025 | -1.17 |
| Jun 30, 2025 | -8.53 |
| Mar 31, 2025 | -1.28 |
| Dec 31, 2024 | -39.04 |
| Sep 30, 2024 | -2.18 |
| Jun 30, 2024 | -37.70 |
| Mar 31, 2024 | -18.84 |
| Dec 31, 2023 | -7.54 |
| Sep 30, 2023 | -1.27 |
| Jun 30, 2023 | -0.59 |
| Mar 31, 2023 | -0.64 |
| Dec 31, 2022 | -19.23 |
| Sep 30, 2022 | -3.02 |
| Jun 30, 2022 | -11.07 |
| Mar 31, 2022 | -7.50 |
| Dec 31, 2021 | -21.07 |
| Sep 30, 2021 | -1.29 |
| Jun 30, 2021 | -0.68 |